Disclosures

May 23, 2021 by in GASTROENTEROLOGY Comments Off on Disclosures

    Financial Disclosures       Dr. Chathur Acharya has no financial or proprietary interest in the materials presented herein. Dr. Jessica R. Allegretti is on the scientific advisory…

read more

Discovery: Emerging Indications

May 23, 2021 by in GASTROENTEROLOGY Comments Off on Discovery: Emerging Indications

10 Discovery Emerging Indications Jessica R. Allegretti, MD, MPH and Zain Kassam, MD, MPH For many years, peptic ulcers were thought to be related to stress and lifestyle factors. Dr….

read more

Frequently Asked Questions

May 23, 2021 by in GASTROENTEROLOGY Comments Off on Frequently Asked Questions

11 Frequently Asked Questions Jessica R. Allegretti, MD, MPH and Zain Kassam, MD, MPH Given that the field of fecal microbiota transplantation (FMT) and microbiome therapeutics is relatively new, there…

read more

| The Role of Fecal Microbiota Transplantation in the Treatment of Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease

May 23, 2021 by in GASTROENTEROLOGY Comments Off on | The Role of Fecal Microbiota Transplantation in the Treatment of Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease

10.6 The Role of Fecal Microbiota Transplantation in the Treatment of Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease Benjamin H. Mullish, MB, BChir, MRCP, PhD Over the course of…

read more

| Other Clostridioides difficile Indications

May 23, 2021 by in GASTROENTEROLOGY Comments Off on | Other Clostridioides difficile Indications

10.1 Other Clostridioides difficile Indications 10.1.1 The Role of Fecal Microbiota Transplantation in the Treatment of Primary Clostridioides difficile Infection Alexander Khoruts, MD Given the evidence of FMT for recurrent…

read more
Get Clinical Tree app for offline access